Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02248194
Other study ID # Tactile ablation
Secondary ID
Status Completed
Phase Phase 2
First received January 22, 2014
Last updated December 30, 2015
Start date April 2010
Est. completion date December 2014

Study information

Verified date December 2015
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority Egypt: Assiut Medical School Ethical Review Board
Study type Interventional

Clinical Trial Summary

Abnormal uterine bleeding (AUB) is any alteration in the pattern or volume of menstrual blood flow and heavy menstrual bleeding affects up to 30% of women at some time during their reproductive years. Abnormal menstruation can be due to conditions such as pregnancy complication uterine fibroids and adenomyosis, but in a large proportion of cases, the etiology is unclear, a condition generally referred to as dysfunctional uterine bleeding (DUB). Treatment options for DUB include symptomatic medical treatment or surgery, traditionally hysterectomy.

Hysteroscopically guided endometrial ablation methods have been shown to be effective and safe alternatives to hysterectomy for management of DUB. These methods require particular skills and experience and a long learning curve to be performed effectively and safely.

Through the past three decades DUB patients in Assiut university hospital were treated with either electrosurgical ablation or hysterectomy. When faced with hysteroscopic challenges during transcervical resection of the endometrium or rollerball coagulation, we used to shift to thermal balloon as backup method . However, expensive uterine balloon could not infrequently be afforded because of financial constrains and limited health resources . Therefore, another method was used as backup for hysteroscopic failures. It was first tried via insulating the conventional double-ended uterine curette then through a specially designed tactile electrosurgical ablation (TEA) probe.The technique of TEA is largely similar to the dilatation and curettage procedure both principally and practically. Hence, the basic requirements for its performance are the general awareness with electrosurgical principles and adequate experience in performing dilatation and curettage. TEA is done by specially designed tactile diathermy probe that carried the job of electrosurgical ablation without hysteroscopy or distension media first in an experimental session that clearly clarified the reproducibility of the depth of thermal damage and safety of the tactile electrosurgical ablator . Thereafter, TEA was successfully performed with satisfactory short and medium term outcomes for ten cases with DUB during an active, relentless bleeding attack. TEA is done under laparoscopic monitoring.

The aim of the present work is to present TEA as a simple, inexpensive, novel backup approach for treatment of DUB.


Recruitment information / eligibility

Status Completed
Enrollment 108
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Female
Age group 40 Years to 50 Years
Eligibility Inclusion Criteria:

- Patients with dysfunctional uterine bleeding aged between 40 to 50 years

- Unsuccessful medical treatment.

- No intrauterine abnormalities.

- Endometrial biopsy negative for atypia and cancer.

- follicle stimulating hormone level not exceeds 30 mills-International unit

- Family complete

- Patients who are not candidate for hysterectomy because of medical or surgical risks.

Exclusion Criteria:

- Coexisting gynecological pathology (e.g. uterovaginal prolapsed, ovarian pathology, pelvic inflammatory disease, cervical atypia).

- Endometrial hyperplasia with atypia and cancer..

- History or evidence of malignancy.

- Hyperplasia in the endometrial biopsy.

- Uterine size more than 12 weeks in size.

- Women with caesarean or myomectomy scar

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Intervention

Device:
Tactile electrosurgical ablation probe

Hysteroscopic endometrial ablation


Locations

Country Name City State
Egypt Woman's Health Hospital-Assiut University. Assiut

Sponsors (2)

Lead Sponsor Collaborator
Mostafa Hussein Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Satisfaction with the treatment at 12 month follow up Satisfaction with the treatment will be measured at 1 year post procedure on 3-point scale—very satisfied, satisfied, and not satisfied. 12 moth No
Primary Change in menstrual status. Menstrual status will be reported as
Normal menstrual flow.
Light menstrual bleeding.
Heavy menstrual bleeding.
The need for hysterectomy.
At 3, 6, 9, and12 months pot operatve. No
Secondary Acceptability of treatment Acceptability of the procedure will be assessed in 3- point scale as cure or acceptable improvement in symptoms, treatment acceptable and would recommend treatment to others or not acceptable 4 weeks No
Secondary Changes in health related quality of life Health-related quality of life parameters will be completed using
Short form-12 (SF12).
Life style questionnaires including Work affection will be measured by the number of days absence from the work due to menses as following, non ,non but work suffer, 1 day and >2 days.
sexual life affection will be measured in two point as no or yes.
At 3, 6, 9, and 12 months post operative. No
Secondary Difference in operative time between the two groups in minutes. Difference in operative time is calculated using a stop watch.The zero minute is the time of starting the procedure. The stop watch is on at the zero minute then sopped at the end of the procedure.time of anesthesia is not included. 0-60 minutes No
Secondary Reporting of any intro-operative complications. Intro-operative complications includes
Cervical laceration.
Perforation of the uterus.
Hemorrhage
Fluid overload.
0-60 minutes. Yes
Secondary Reporting of any technical complications. Technical complications for transcervical resection of the endometrium (TCRE) includes
Poor uterine distention.
Slow clearance of the debris.
Inefficient cutting.
Poor visualization.
problem of diathermy.
Problems with the camera.
problems with light source.
Technical complications for tactile electrosurgical ablation (TEA) includes
Insulation problem.
Connection problem.
Inefficient diathermy power.
0-60 minutes Yes
Secondary Difference in post-operative pain score using visual analogue scale between the two groups. Difference in post-operative pain score using visual analogue scale from 1-10. 4 hours. No
Secondary Time needed for post operative recovery (days) of pain, vaginal bleeding, vaginal discharge, till full recovery and till return to work. 28 days post operative No
Secondary Length of hospital stay in days Length of hospital stay in days is calculated from the day of operation till day of discharge. up to 2 days No
Secondary Difference in the cost of the two surgical procedure. Direct cost of the surgical procedure itself is calculated.The cost of the TCRE procedure will include the cost paid for the hysteroscopic unit and the cost of glycine used as distension media.The cost of the TEA procedure will include the cost of laparoscopy, the cost of TEA probe, and the cost of diagnostic hysteroscopy. The cost of the investigations, anesthesia, pre and post operative treatments will be excluded from analysis as they are the same for both groups. up to one hour. No